Bioventus Inc. (BVS)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$0.17
Street estimate
Revenue target
$149.5M
Street estimate
Trailing EPS (avg 4Q)
$0.19
Beat rate last 4: 75%
Latest EPS YoY
+4.8%
vs 2025-08-06
Latest revenue YoY
+3.8%
How results look so far
Trailing revenue (avg 4Q)
$145.5M
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 5, 2026
EPS beat
EPS actual / est
$0.22 / $0.22
+1.7%
Revenue actual / est
$153.2M / $155.4M
-1.4%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $0.17 | Pending | — | $149.5M | Pending | — |
| 8/5/2026 | $0.22 | $0.22 | +1.7% | $155.4M | $153.2M | -1.4% |
| 5/6/2026 | $0.09 | $0.15 | +66.7% | $129.9M | $132.1M | +1.7% |
| 5/5/2026upcoming | $0.09 | Pending | — | $129.9M | Pending | — |
| 3/5/2026 | $0.22 | $0.24 | +9.1% | $154.9M | $157.9M | +1.9% |
| 11/4/2025 | $0.21 | $0.15 | -30.2% | $155.7M | $138.7M | -11.0% |
| 8/6/2025 | $0.22 | $0.21 | -4.5% | $138.8M | $147.7M | +6.4% |
| 5/6/2025 | $0.06 | $0.08 | +33.3% | $145.9M | $123.9M | -15.1% |
| 3/11/2025 | $0.08 | $0.15 | +87.5% | $124.5M | $153.6M | +23.4% |
| 11/5/2024 | $0.06 | $0.06 | 0.0% | $144.8M | $139.0M | -4.0% |
| 8/6/2024 | $0.07 | $0.19 | +171.4% | $137.6M | $151.2M | +9.9% |
| 5/7/2024 | $-0.05 | $0.07 | +240.0% | $118.4M | $129.5M | +9.4% |
| 3/12/2024 | $0.06 | $0.07 | +16.7% | $124.0M | $135.4M | +9.2% |
| 11/7/2023 | $0.06 | $0.05 | -16.7% | $124.0M | $120.8M | -2.6% |
| 8/8/2023 | $0.03 | $0.14 | +366.7% | $129.2M | $137.1M | +6.1% |
| 5/16/2023 | $-0.11 | $-0.26 | -136.4% | $116.6M | $119.1M | +2.1% |
| 3/31/2023 | $0.05 | $-0.06 | -220.0% | $132.7M | $125.8M | -5.2% |
| 11/21/2022 | $0.13 | $0.05 | -61.5% | $141.6M | $128.7M | -9.1% |
| 11/8/2022 | $0.13 | $0.05 | -61.5% | $141.6M | $137.1M | -3.2% |
| 8/11/2022 | $0.14 | $0.10 | -28.6% | $138.3M | $140.3M | +1.4% |
| 5/10/2022 | $0.05 | $0.04 | -16.7% | $117.7M | $117.3M | -0.3% |
| 3/10/2022 | $0.20 | $0.26 | +30.0% | $130.2M | $130.4M | +0.1% |
| 11/9/2021 | $0.13 | $0.25 | +92.3% | $105.0M | $108.9M | +3.8% |
| 8/10/2021 | $0.10 | $0.16 | +60.0% | $109.8M | $109.8M | 0.0% |
| 5/12/2021 | $-0.01 | $-0.02 | -57.5% | $478.4M | $81.8M | -82.9% |
| 3/25/2021 | $0.23 | $2.32 | +908.7% | — | $98.6M | — |
| 2/12/2021 | — | $0.15 | — | — | $85.9M | — |
| 6/30/2020 | — | $-0.10 | — | — | $58.0M | — |
| 3/31/2020 | — | $0.19 | — | — | $78.6M | — |
| 12/31/2019 | — | $1.15 | — | — | $97.6M | — |
| 9/28/2019 | — | $0.07 | — | — | $82.2M | — |
| 6/29/2019 | — | $-0.05 | — | — | $80.2M | — |
| 3/29/2019 | — | $-0.05 | — | — | $80.2M | — |
| 3/31/2016 | — | $-0.11 | — | — | $65.4M | — |
| 3/31/2015 | — | $-0.37 | — | — | $53.4M | — |
Need BVS data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.